These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3215276)

  • 21. Evidence for delta receptor mediation of [D-Pen2,D-Pen5]-enkephalin (DPDPE) analgesia in mice.
    Heyman JS; Mosberg HI; Porreca F
    NIDA Res Monogr; 1986; 75():442-5. PubMed ID: 2828989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrophysiological demonstration of mu, delta and kappa opioid receptors in the ventral pallidum.
    Mitrovic I; Napier TC
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1260-70. PubMed ID: 7891342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine.
    Calcagnetti DJ; Holtzman SG
    Pharmacol Biochem Behav; 1991 Jan; 38(1):185-90. PubMed ID: 2017444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of specific opioid receptor agonists on rat pup isolation calls.
    Carden SE; Barr GA; Hofer MA
    Brain Res Dev Brain Res; 1991 Sep; 62(1):17-22. PubMed ID: 1662121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential involvement of ventral tegmental mu, delta and kappa opioid receptors in modulation of basal mesolimbic dopamine release: in vivo microdialysis studies.
    Devine DP; Leone P; Pocock D; Wise RA
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1236-46. PubMed ID: 7690399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spinal dynorphin A (1-17): possible mediator of antianalgesic action.
    Fujimoto JM; Arts KS; Rady JJ; Tseng LF
    Neuropharmacology; 1990 Jul; 29(7):609-17. PubMed ID: 1974711
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of mu and kappa opioid receptors in conditional fear-induced analgesia: the antagonistic actions of nor-binaltorphimine and the cyclic somatostatin octapeptide, Cys2Tyr3Orn5Pen7-amide.
    Fanselow MS; Calcagnetti DJ; Helmstetter FJ
    J Pharmacol Exp Ther; 1989 Sep; 250(3):825-30. PubMed ID: 2570868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antinociception produced by receptor selective opioids: modulation of spinal antinociceptive effects by supraspinal opioids.
    Miaskowski C; Levine JD
    Brain Res; 1992 Nov; 595(1):32-8. PubMed ID: 1334770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
    Paul D; Bodnar RJ; Gistrak MA; Pasternak GW
    Eur J Pharmacol; 1989 Sep; 168(3):307-14. PubMed ID: 2555205
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alteration of thermoregulatory set point with opioid agonists.
    Spencer RL; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1990 Feb; 252(2):696-705. PubMed ID: 2313595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of central administration of highly selective opioid mu-, delta- and kappa-receptor agonists on plasma luteinizing hormone (LH), prolactin, and the estrogen-induced LH surge in ovariectomized ewes.
    Walsh JP; Clarke IJ
    Endocrinology; 1996 Sep; 137(9):3640-8. PubMed ID: 8756528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
    Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medial preoptic-anterior hypothalamic area involvement in the suppression of pulsatile LH release by a mu-opioid agonist in the ovariectomized rat.
    Mallory DS; Gallo RV
    Brain Res Bull; 1990 Aug; 25(2):251-7. PubMed ID: 2171721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Opioid receptor subtype involvement in maternal behavior in lactating rats.
    Mann PE; Kinsley CH; Bridges RS
    Neuroendocrinology; 1991 May; 53(5):487-92. PubMed ID: 1651460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glial growth is regulated by agonists selective for multiple opioid receptor types in vitro.
    Stiene-Martin A; Hauser KF
    J Neurosci Res; 1991 Aug; 29(4):538-48. PubMed ID: 1665190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of nitric oxide in peripheral antinociception mediated by kappa- and delta-opioid receptors.
    Nozaki-Taguchi N; Yamamoto T
    Anesth Analg; 1998 Aug; 87(2):388-93. PubMed ID: 9706936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential modulation by [D-Pen2, D-Pen5]enkephalin and dynorphin A-(1-17) of the inhibitory bladder motility effects of selected mu agonists in vivo.
    Sheldon RJ; Nunan L; Porreca F
    J Pharmacol Exp Ther; 1989 May; 249(2):462-9. PubMed ID: 2566676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional haemodynamic effects of mu-, delta-, and kappa-opioid agonists microinjected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats.
    Bachelard H; Pître M
    Br J Pharmacol; 1995 Jun; 115(4):613-21. PubMed ID: 7582480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
    Stein C; Millan MJ; Shippenberg TS; Peter K; Herz A
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1269-75. PubMed ID: 2539460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of intrathecal opioid-receptor agonists on visceral noxious stimulation in rabbits.
    Borgbjerg FM; Frigast C; Madsen JB; Mikkelsen LF
    Gastroenterology; 1996 Jan; 110(1):139-46. PubMed ID: 8536850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.